Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma
Abstract Background This study aims to evaluate the efficacy and safety of camrelizumab in combination with chemotherapy as a second-line treatment for patients with locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma (ESCC). Methods In this retrospective, single-center obs...
Saved in:
Main Authors: | Yinfang Gu, Xiaofang Zou, Junlin Zhu, Guowu Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-025-03690-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma
by: Francesca Huwyler, et al.
Published: (2024-12-01) -
KLF5 promotes esophageal squamous cell carcinoma radioresistance by targeting the Keap1-Nrf2 pathway
by: Yang Wang, et al.
Published: (2025-02-01) -
Prognostic value of FCER1G expression and M2 macrophage infiltration in esophageal squamous cell carcinoma
by: Wei Peng, et al.
Published: (2025-02-01) -
Aberrant SNHG expression predicts poor prognosis in esophageal cancer using meta-analysis and bioinformatics analysis
by: Ke Shi, et al.
Published: (2025-02-01) -
FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma
by: Yu Ishizuya, et al.
Published: (2025-02-01)